Publicacións nas que colabora con Milagros Rocha Barajas (120)

2024

  1. Calorie restriction modulates mitochondrial dynamics and autophagy in leukocytes of patients with obesity

    Free Radical Biology and Medicine, Vol. 225, pp. 677-686

  2. Gingival inflammation and leukocyte–endothelium cell interactions in women with polycystic ovary syndrome

    Journal of Periodontology

  3. Molecular circadian clock disruption in the leukocytes of individuals with type 2 diabetes and overweight, and its relationship with leukocyte–endothelial interactions

    Diabetologia, Vol. 67, Núm. 10, pp. 2316-2328

2023

  1. Effects of GLP-1 receptor agonists on mitochondrial function, inflammatory markers and leukocyte-endothelium interactions in type 2 diabetes

    Redox biology, Vol. 66, pp. 102849

  2. Mitochondrial Dysfunction and Mitophagy in Type 2 Diabetes: Pathophysiology and Therapeutic Targets

    Antioxidants and Redox Signaling, Vol. 39, Núm. 4-6, pp. 278-320

2022

  1. Gold Nanoparticles Supported on Ceria Nanoparticles Modulate Leukocyte–Endothelium Cell Interactions and Inflammation in Type 2 Diabetes

    Antioxidants, Vol. 11, Núm. 11

  2. Impact of Roux-en-Y Gastric Bypass on Mitochondrial Biogenesis and Dynamics in Leukocytes of Obese Women

    Antioxidants, Vol. 11, Núm. 7

  3. Metformin modulates mitochondrial function and mitophagy in peripheral blood mononuclear cells from type 2 diabetic patients

    Redox Biology, Vol. 53

  4. Mitochondrial redox impairment and enhanced autophagy in peripheral blood mononuclear cells from type 1 diabetic patients

    Redox Biology, Vol. 58

  5. Roux-en-Y Gastric Bypass Modulates AMPK, Autophagy and Inflammatory Response in Leukocytes of Obese Patients

    Biomedicines, Vol. 10, Núm. 2

  6. The Role of Mitochondrial Dynamic Dysfunction in Age-Associated Type 2 Diabetes

    World Journal of Men's Health, Vol. 40

2021

  1. Characterization of differentially expressed circulating mirnas in metabolically healthy versus unhealthy obesity

    Biomedicines, Vol. 9, Núm. 3

  2. Does Metformin Modulate Mitochondrial Dynamics and Function in Type 2 Diabetic Patients?

    Antioxidants and Redox Signaling, Vol. 35, Núm. 5, pp. 377-385

  3. Does empagliflozin modulate leukocyte–endothelium interactions, oxidative stress, and inflammation in type 2 diabetes?

    Antioxidants, Vol. 10, Núm. 8

  4. Micrornas and oxidative stress: An intriguing crosstalk to be exploited in the management of type 2 diabetes

    Antioxidants, Vol. 10, Núm. 5

  5. Testosterone administration increases leukocyte-endothelium interactions and inflammation in transgender men

    Fertility and Sterility, Vol. 115, Núm. 2, pp. 483-489

  6. Therapeutic implications of targeting antioxidants to mitochondria

    Mitochondrial Dysfunction and Nanotherapeutics: Aging, Diseases, and Nanotechnology-Related Strategies in Mitochondrial Medicine (Elsevier), pp. 459-475

2020

  1. Association between proinflammatory markers, leukocyte–endothelium interactions, and carotid intima–media thickness in type 2 diabetes: Role of glycemic control

    Journal of Clinical Medicine, Vol. 9, Núm. 8, pp. 1-19

  2. Effect of non-surgical periodontal treatment on oxidative stress markers in leukocytes and their interaction with the endothelium in obese subjects with periodontitis: A pilot study

    Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-16

  3. Effect of roux-en-y bariatric bypass surgery on subclinical atherosclerosis and oxidative stress markers in leukocytes of obese patients: A one-year follow-up study

    Antioxidants, Vol. 9, Núm. 8, pp. 1-14